FDA approves first treatment for Erdheim-Chester Disease
On Nov. 6, the U.S. Food and Drug Administration (FDA) expanded approval of Zelboraf (vemurafenib) to treat certain adult patients…
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.